Health Care/Hospital

Strategic Partnership | Sanyou Bio and Korea's FatiAbGen Join Forces to Expand the Global Biopharma Market

SHANGHAI, Nov. 27, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") andSouth Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a comprehensive strategic collaboration agreement covering joint project development, exclusive representation in the K...

2025-11-27 22:00 1095

Once-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical Study (GRADUAL-3) of the First Chinese Once-Monthly GLP-1 RA for Weight Management

BEIJING, Nov. 27, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, stock code: 603087.SH) announced the initiation of GRADUAL-3, its third large-scale phase 3 clinical study of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) bofanglutide (research code: GZR18) injection in adult...

2025-11-27 16:57 879

IASO Bio Announces BLA Approval of Fucaso (Equecabtagene Autoleucel) by the Hong Kong Department of Health for the Treatment of Relapsed or Refractory Multiple Myeloma

SHANGHAI and NANJING, China and PLEASANTON, Calif., Nov. 27, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic mali...

2025-11-27 13:44 844

GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology

YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published inThe American Journal of Gastroenterology(AJG). GC Genom...

2025-11-27 13:00 807

SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- SK Biopharmaceuticals, CO., Ltd., a biotech company specializing in ...

2025-11-27 10:39 957

Patronus Biotech receives grant to evaluate a novel malaria vaccine and adjuvant to support affordable access and use in global health

SINGAPORE, Nov. 27, 2025 /PRNewswire/ -- Patronus Biotech today announced a grant from the Gates Foundation to accelerate the development of its novel malaria vaccine and adjuvant program to support affordable access and use in global health. The funding will enable the evaluation of an innovativ...

2025-11-27 09:00 784

TCI Biotech Inaugurates Advanced Performance Nutrition Research Center, Expands Into Brain Science to Accelerate Next-Generation Health Innovation

SALT LAKE CITY, Nov. 26, 2025 /PRNewswire/ -- TCI Biotech (TCI Co., Ltd.), a global CDMO+ specializing in functional foods, nutraceuticals, and beauty supplementation, today announced the launch of the TCI Advanced Performance Nutrition Research Center, a new innovation hub focused on high-perfor...

2025-11-27 00:00 824

Healgen Scientific Spotlights the Rapid Check® COVID-19/Flu A&B Antigen Test to Help Families Stay Prepared for the Respiratory Virus Season

HOUSTON, Nov. 26, 2025 /PRNewswire/ -- As the holiday season approaches, gatherings among family and friends are expected to increase the risk of respiratory virus transmission, including COVID-19 and influenza. In response, Healgen® Scientific highlights the Rapid Check® COVID-19/Flu A&B Antigen ...

2025-11-27 00:00 774

China Cycle 2026: Building An Innovation Driven, Intelligence-led Future

SHANGHAI, Nov. 26, 2025 /PRNewswire/ -- The 34th China International Bicycle Fair (China Cycle 2026) is expected to unveil the grand exhibition fromMay 5 to 8, 2026 at the Shanghai New International Expo Center (SNIEC), themed "Innovation-Driven, Intelligence-Led Future." Building on three decade...

2025-11-26 22:10 671

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA®  (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

* Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn's disease (CD) * Findings support the therapeutic potential of ZYMFENTRA in addressing ...

2025-11-26 14:48 1434

Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals

HONG KONG, Nov. 26, 2025 /PRNewswire/ -- In a groundbreaking new episode, CNN's long-running seriesVital Signs delves into the cutting-edge science of hibernation, revealing how the secrets of the animal kingdom could unlock revolutionary advancements in human health, from fighting cancer and hea...

2025-11-26 14:44 829

Renalys Pharma Announces Positive Topline Results from Phase III Study of Sparsentan in Japanese Patients with IgA Nephropathy

– In a Phase 3 clinical study evaluating the efficacy and safety of sparsentan in Japanese patients with IgA nephropathy (N=35), the percent change from baseline in the 24-hour urine protein-to-creatinine ratio at Week 36, which was the study's primary endpoint, was -58.54%. Sparsentan was well-t...

2025-11-26 14:00 815

Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)

DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program. This initia...

2025-11-26 13:45 776

Chiron Medical Advances Women's Health with Expanded "1:1 Breast Health Empowerment Charity Campaign"

300 Free 3D Mammogram Screenings Donated to Community Women, Championing Self-Care and Compassionate Support HONG KONG, Nov. 26, 2025 /PRNewswire/ -- Building on its commitment to accessible healthcare, Chiron Medical Group (Referred as "Chiron") launched the "1:1 Breast Health Empowerment Chari...

2025-11-26 13:03 718

The Unseen Itch: Over Half of Singaporeans With Eczema Struggle With Sleep Loss, Shame and Social Withdrawal Due to Itch

A recently concluded survey by Medical Channel Asia sheds light on the debilitating effects of constant itch caused by eczema.  SINGAPORE, Nov. 25, 2025 /PRNewswire/ -- A new ground-up survey "The Unseen Itch: How Eczema Disrupts Daily Life inSingapore" by Medical Channel Asia

2025-11-26 10:33 1078

Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru

First cyclotron outside Klang Valley to anchor Malaysia's advanced cancer care ecosystem KEY-HIGHLIGTHS * RM500 million investment in advanced cancer care infrastructure * State-of-the-art diagnostic and treatment facilities, including a nuclear medicine centre * First cyclotron outside th...

2025-11-26 10:00 898

Triple the Probiotics, Triple the Relief: Life-Space Launches Triple Strength Probiotics in Southeast Asia

Engineered by Australia's leading probiotics expert, this high CFU probiotic delivers the ultimate gut defense, helping to reduce gut transit time by up to 18 hours. SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Life-Space, Australia's No.1 probiotic brand, proudly unveilsTriple Strength Probiotics, ...

2025-11-26 09:57 987

Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America

SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered inBuenos Aires, Argentina, with decades of experience in ...

2025-11-26 09:06 1265

Professor Chan Heum Park's Team at Hallym University Chuncheon Sacred Heart Hospital Sends Their Self-Developed "BioCabinet" to Space Aboard Nuri Rocket

SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- Chan Hum Park, M.D., Ph.D., Professor of Otolaryngology at Hallym University Chuncheon Sacred Heart Hospital and Director of the Nano-Bio Regenerative Medical Institute at Hallym University, leads the research team whose space biology payload, Bio...

2025-11-26 07:30 945

Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition

The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers. IVT-8086 is the only cancer therapeutic that targets multiple cell types associated with canc...

2025-11-25 23:06 637
1 ... 45678910 ... 860